Hospitalized cardiovascular events in patients with diabetic macular edema

被引:23
|
作者
Nguyen-Khoa, Bao-Anh [1 ]
Goehring, Earl L., Jr. [1 ]
Werther, Winifred [2 ,3 ]
Fung, Anne E. [3 ]
Do, Diana V. [4 ]
Apte, Rajendra S. [5 ]
Jones, Judith K. [1 ]
机构
[1] Degge Grp Ltd, Arlington, VA 22209 USA
[2] Vertex Pharmaceut, Boston, MA USA
[3] Pacific Eye Associates Ltd, San Francisco, CA USA
[4] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA
[5] Washington Univ, St Louis, MO USA
来源
BMC OPHTHALMOLOGY | 2012年 / 12卷
关键词
CORONARY-HEART-DISEASE; RETINOPATHY; MORTALITY; RISK; ADJUSTMENT; INDEX;
D O I
10.1186/1471-2415-12-11
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Microvascular and macrovascular complications in diabetes stem from chronic hyperglycemia and are thought to have overlapping pathophysiology. The aim of this study was to investigate the incidence rate of hospitalized myocardial infarctions (MI) and cerebrovascular accidents (CVA) in patients with diabetic macular edema (DME) compared with diabetic patients without retinal diseases. Methods: This was a retrospective cohort study of a commercially insured population in an administrative claims database. DME subjects (n = 3519) and diabetes controls without retinal disease (n = 10557) were matched by age and gender. Healthcare claims were analyzed for the study period from 1 January 2002 to 31 December 2005. Incidence and adjusted rate ratios of hospitalized MI and CVA events were then calculated. Results: The adjusted rate ratio for MI was 2.50 (95% CI: 1.83-3.41, p<0.001) for DME versus diabetes controls. Predictors of MI events were heart disease, history of acute MI, and prior use of antiplatelet or anticoagulant drugs. The adjusted rate ratio for CVA was 1.98 (95% CI: 1.39-2.83, p<0.001) for DME versus diabetes controls. Predictors of CVA events were cardiac arrhythmia, Charlson comorbidity scores, history of CVA, hyperlipidemia, and other cerebrovascular diseases. Conclusion: Event rates of MI or CVA were higher in patients with DME than in diabetes controls. This study is one of few with sufficient sample size to accurately estimate the relationship between DME and cardiovascular outcomes.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Introduction: Improving Outcomes for Patients With Diabetic Macular Edema
    Puliafito, Carmen A.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (10): : S4 - S4
  • [42] Choroidal Thickness Change in Patients With Diabetic Macular Edema
    Eliwa, Tamer F.
    Hegazy, Omnia S.
    Mahmoud, Safaa S.
    Almaamon, Tarek
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (12): : 970 - +
  • [43] Increased Wnt Modulators in Patients with Diabetic Macular Edema
    Ji, Bokjun
    Lee, Jiyoung
    Lim, Daehan
    Kim, Hyung chan
    Chung, Hyewon
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [44] Choroidal thickness is reduced in patients with diabetic macular edema
    Ferreras, Antonio
    Abadia, Beatriz
    Calvo, Pilar
    Sunen, Ines
    Bartol, Francisco
    Belen Pajarin, Ana
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [45] Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy
    O'Fee, John R.
    Juliano, Joseph
    Moshfeghi, Andrew A.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (07) : 2191 - 2200
  • [46] Foveal choroidal thickness in patients with diabetic retinopathy and diabetic macular edema
    Varughese, Rachel Sarah
    Rewbury, Rebecca
    Want, Andrew
    Chong, Victor
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [47] Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy
    John R. O’Fee
    Joseph Juliano
    Andrew A. Moshfeghi
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 2191 - 2200
  • [48] Increased health care utilization among patients with diabetic macular edema compared with diabetic patients without edema
    Wallick, Chris John
    Hansen, Ryan N.
    Campbell, Joanna
    Kowalski, Jonathan W.
    Kiss, Szilard
    Sullivan, Sean D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [49] Accelerated Anti-VEGF Dosing for Treatment Resistant Macular Edema in Patients with Diabetic Macular Edema
    Kim, Yonwook Justin
    Bryant, Tara
    Thangappan, Archana Seethala
    Subramanian, Manju
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [50] Inflammation and Diabetic Macular Edema
    Ucgun, Nil Irem
    Fikret, Cenk Zeki
    Yildirim, Zuhal
    OPHTHALMOLOGICA, 2014, 232 : 25 - 25